| 000 | 02455nam a2200493 i 4500 | ||
|---|---|---|---|
| 999 |
_c282226 _d282226 |
||
| 001 | ocn799785338 | ||
| 003 | OCoLC | ||
| 005 | 20190701150231.0 | ||
| 006 | m o d f | ||
| 007 | cr gn||||||||| | ||
| 008 | 120715s1998 dcua ob f000 0 eng c | ||
| 040 |
_aPUCPR _beng _erda _epn _cOCLCE _dOCLCQ _dOCLCA _dOCLCF _dOCLCQ _dOCLCO _dOCLCA _dCWCLL _dNJR _dOCLCQ _dINARC _dUWO _dOCLCQ _dGPO _dMvI |
||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 074 | _a1016-C (online) | ||
| 086 | 0 | _aY 4.G 74/7:OF 2/6 | |
| 099 | _aY 4.G 74/7:OF 2/6 | ||
| 110 | 1 |
_aUnited States. _bCongress. _bHouse. _bCommittee on Government Reform and Oversight. _bSubcommittee on Human Resources and Intergovernmental Relations, |
|
| 245 | 1 | 0 |
_aOff-label drug use and FDA review of supplemental drug applications : _bhearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996. |
| 264 | 1 |
_aWashington : _bU.S. Government Printing Office, _c1998. |
|
| 300 |
_a1 online resource (iii, 152 pages) : _billustrations |
||
| 336 | _btxt | ||
| 337 |
_bc _2rdamedia |
||
| 338 |
_bcr _2rdacarrier |
||
| 500 | _aCRDP Program record. | ||
| 504 | _aIncludes bibliographical references. | ||
| 588 | _aDescription based on online resource; title from PDF title page (govinfo, viewed May 2, 2019). | ||
| 776 | 0 | 8 |
_iPrint version: _aUnited States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on Human Resources and Intergovernmental Relations. _tOff-label drug use and FDA review of supplemental drug applications _w(DLC) 98133428 _w(OCoLC)38469061 |
| 856 | 4 | 0 | _uhttps://purl.fdlp.gov/GPO/gpo119756 |
| 050 | 4 |
_aKF27 _b.G663 1996j |
|
| 610 | 1 | 0 |
_aUnited States. _bFood and Drug Administration _xRules and practice. |
| 610 | 1 | 7 |
_aUnited States. _bFood and Drug Administration. _2fast |
| 650 | 0 |
_aDrug utilization _zUnited States. |
|
| 650 | 0 |
_aDrug approval _zUnited States. |
|
| 650 | 0 |
_aDrugs _xLabeling _xGovernment policy _zUnited States. |
|
| 650 | 0 |
_aDrugs _xPrescribing _zUnited States. |
|
| 650 | 0 |
_aDrugs _xSide effects _zUnited States. |
|
| 650 | 1 | 2 | _aOff-Label Use. |
| 650 | 7 |
_aDrugs _xLabeling. _2fast |
|
| 650 | 7 |
_aDrugs _xPrescribing. _2fast |
|
| 651 | 7 |
_aUnited States. _2fast |
|
| 655 | 7 |
_aLegislative hearings. _2lcgft |
|
| 942 |
_2sudocs _c8 |
||